<unk> , sold under the brand name Omidria, is a combination drug used during cataract surgery or intraocular lens replacement to prevent intraoperative miosis and to reduce postoperative pain. It contains<unk>  and<unk> .<unk>  was approved for medical use in the United States in May 2014, and in the European Union in July 2015.
Phenylephrine/ketorolac
Bupivacaine/meloxicam
Butalbital/acetaminophen
Celecoxib/tramadol
Hydrocodone/paracetamol
Naphazoline/pheniramine
Naproxen/diphenhydramine
Sumatriptan/naproxen sodium